Clinical Trials Logo

Chronic Stable Angina clinical trials

View clinical trials related to Chronic Stable Angina.

Filter by:

NCT ID: NCT06249581 Active, not recruiting - Clinical trials for Chronic Stable Angina

Pharmacokinetics of AUX-001 40mg Once-daily in Healthy Subjects Under Fasting and Fed Conditions

Start date: November 27, 2023
Phase: Early Phase 1
Study type: Interventional

Exploratory, single-dose, open-label, pharmacokinetic study to establish uptake, plasma levels safety and tolerability of orally administered AUX-001 on an empty stomach (i.e, fasting) as well as after a meal (i.e. fed) in healthy volunteers.

NCT ID: NCT06224582 Completed - Clinical trials for Chronic Stable Angina

Yinxingmihuan Oral Solution in Treatment of Chest Pain After PCI

Start date: December 30, 2020
Phase: N/A
Study type: Interventional

A prospective, multi-center, double-blind, randomized, placebo-controlled trial is conducted to evaluate the efficacy and safety of Yinxingmihuan oral solution in the treatment of chest pain after percutaneous coronary intervention (PCI) in patients with stable angina. Patients should undergo at least 1-week standardized medical treatment phase before randomization. The primary end point is the 12-week angina frequency assessed on the basis of Seattle Angina Questionnaire (SAQ) subscales. The main secondary endpoint is the improvement of anxiety assessed by Hamilton Anxiety Scale (HAMA) to evaluate its effectiveness for chest pain caused by psychological factors.

NCT ID: NCT04498962 Not yet recruiting - Vascular Dementia Clinical Trials

The Effect of Danzhu Fuyuan Granule as Adjunctive Therapy for Chronic Stable Angina, Vascular Dementia and Idiopathic Membranous Nephropathy: A Bayesian Basket Trial

Start date: August 2020
Phase: N/A
Study type: Interventional

This study is designed as a bayesian basket trial , which aims to evaluate the efficacy of Danzhu Fuyuan Granule in patients with Chronic Stable Angina, Vascular Dementia and Idiopathic Membranous Nephropathy

NCT ID: NCT03963609 Completed - Clinical trials for Chronic Stable Angina

Multi-slice CT Coronary Angiography in Patients With Stable Angina

Start date: January 1, 2016
Phase:
Study type: Observational

early identification of vulnerable plaques by remodeling index prior to rupture and development of acute event is of considerable importance especially by a reliable non-invasive method as CT coronary angiography.

NCT ID: NCT03834155 Recruiting - Clinical trials for Coronary Artery Disease

Enhancing Cardiac Rehabilitation Through Behavioral Nudges

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

Adherence to cardiac rehabilitation is poor, and worse for minorities, women, and those with lower levels of education. Patients less likely to be referred to and complete cardiac rehab are at highest risk of adverse outcomes and thus have the most to gain from participation in cardiac rehab. To improve participation, healthcare systems need to limit barriers to enrollment and promote adherence to rehabilitation.

NCT ID: NCT03507361 Recruiting - Clinical trials for Chronic Stable Angina

Myocardial Damage and Music Study

MYDA-MUSIC
Start date: May 2, 2018
Phase: N/A
Study type: Interventional

MYDA-MUSIC study is a randomized, double blind (operator and analyst) study performed in San Filippo Neri Hospital, Roma, Italy and in Di Venere Hospital, Bari, Italy. The planned study duration is 12 months. The objectives are to assess the effects of heart-rate-variability based music on the incidence and magnitude of peri-procedural myocardial damage caused by coronary angioplasty in stable patients. 443 patients with chronic stable angina scheduled for a coronary angiography and possible ad hoc angioplasty will be randomized to receive music or dumb earphones.

NCT ID: NCT03486561 Not yet recruiting - Clinical trials for Chronic Stable Angina

Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine)

MIDA
Start date: April 1, 2018
Phase: Phase 4
Study type: Interventional

The rationale of MIDA trial is to determine efficacy and tolerability of ranolazine molecule among Pakistan population and obtain firsthand knowledge about the molecule ranolazine.

NCT ID: NCT03392948 Active, not recruiting - Clinical trials for Acute Myocardial Infarction

PERcutaneouS Coronary intErventions in Patients Treated With Oral Anticoagulant Therapy

PERSEO
Start date: February 9, 2018
Phase:
Study type: Observational [Patient Registry]

Approximately 5 to 8% of patients undergoing percutaneous coronary interventions requires chronic anticoagulant therapy due to atrial fibrillation or other clinical entities. There are many possible different combinations of the antithrombotic therapy after stent implantation in these patients. Aim of this observational study is to evaluate the real world antithrombotic treatment in patients requiring anticoagulant therapy undergoing stent implantation and to compare the clinical outcome of patients treated with new oral anticoagulant drugs compared to warfarin. The study is prospective, performed in different Italian hospitals and aimed to enroll 1080 patients with a 1 year follow up

NCT ID: NCT03350737 Completed - Clinical trials for Chronic Stable Angina

Coronary Arteriogenetic Heparinized Exercise

CARHEXA
Start date: February 1, 2013
Phase: N/A
Study type: Interventional

This study evaluates the addition of heparin to a 2-week cycle of physical rehabilitation in the treatment of refractory angina. Half of the patients will undergo heparin-primed physical rehabilitation, while the other half will undergo only physical rehabilitation.

NCT ID: NCT03346278 Terminated - Clinical trials for Myocardial Infarction

Text Message Intervention to Improve Cardiac Rehab Participation

Start date: November 7, 2017
Phase: N/A
Study type: Interventional

Cardiac rehabilitation (CR) is strongly recommended for patients with coronary heart disease. However, patient enrollment and completion of cardiac rehabilitation is low. This study will examine if a mobile phone intervention that uses a text messaging program can successfully promote participation in cardiac rehabilitation.